Search for: "Pharmaceuticals USA, Inc." Results 101 - 120 of 917
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Dec 2020, 1:00 pm by Olivia Cross
Instead, the ANDA applicants must simply prove that their proposed generic product is bioequivalent of an existing pharmaceutical, often called the innovator drug. [read post]
2 Nov 2020, 3:07 pm by David Jensen
For the work, CIRM awarded Rocket Pharmaceuticals, Inc., a publicly traded, New York-based firm, $6.6 million in May 2019. [read post]
2 Nov 2020, 1:41 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA, Inc., is getting attention for potentially “endangering” the practice of skinny labelling. [read post]
8 Oct 2020, 9:59 pm by Patent Docs
What Quantum of Culpable Conduct Is Required for an ANDA Applicant to Induce Infringement? [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
5 Oct 2020, 10:25 am by Dennis Crouch
Mylan Pharmaceuticals Inc., No. 19-1451; Arthrex, Inc. v. [read post]
11 Sep 2020, 7:06 am by Peter Briccetti
The U.S. government filed a False Claims Act case against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
30 Aug 2020, 10:19 am by Ben Vernia
According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
13 Aug 2020, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
31 Jul 2020, 4:00 pm by Pete Strom
Pharmaceutical Manufacturer that Makes Generic Lipitor Will Pay Millions for Dangerous Drugs A subsidiary of India’s largest pharmaceutical company, Ranbaxy USA Inc, has agreed to pay the United States federal government a record $500 million in criminal and civil fines for selling adulterated drugs, including the generic version of Lipitor, and lying to regulators during the year-long investigation. [read post]
11 Jun 2020, 11:30 pm by Schachtman
” Now the claims here are quite unsettling, especially considering that they were lodged in a defense brief, in an MDL, with many cases at stake, made on behalf of an important pharmaceutical company, represented by two large, capable national or international law firms. [read post]
5 Jun 2020, 1:49 pm by Rebecca Tushnet
Pierre Fabre Dermo-Cosmetique USA, Inc., 2020 WL 2988587, No. 19-23616-Civ-Scola (S.D. [read post]